top of page

Search Results

Search results for "fluorescent ligands"

Results found for "fluorescent ligands"

  • 📰 GPCR Weekly News, February 12 to 18, 2024

    Drugs, and more Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand impacts on metabolism of polyamines, mRNA splicing, regulation of RAS by GAPs, neddylation and GPCR ligand in Pharmacology and Drug Discovery March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)

    therapy Rational design of highly stabilized and selective adrenomedullin analogs Novel multi-target ligands scaffolds-synthesis, biological activity, and structural evaluation Flavonoids as G Protein-coupled Receptors Ligands Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • 📰 GPCR Weekly News, November 20 to 26, 2023

    Activation: GAIN Domain Unfolding and Dissociation in Adhesion GPCRs Molecular sensing of mechano- and ligand-dependent receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • Odorant receptors – a bit of smell for drug discovery

    the immune system ORs are expressed in different blood cells where aroma compounds from butter, known ligands In the GI tract OR ligands drive an intracellular cascade that results in enhanced serotonin release antagonists, where the starting point can be using licensed drugs (for drug repurposing) and endogenous ligands Odorants, the natural ligands, could potentially be used as ligands and particular forms of odorant delivery ORs research to advance drug discovery include the deorphanization and characterization of relevant ligands

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator. α1-adrenoceptor ligands A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice. Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Ligands with Label-free Impedance , Endocrinology, and Taste Structure-based design of novel melanin-concentrating hormone receptor-1 ligands New paradigms in purinergic receptor ligand discovery.

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    Impact of membrane lipid polyunsaturation on dopamine D2 receptor ligand binding and signaling GPCR Binders Application of computational methods for class A GPCR Ligand discovery. Methods & Updates in GPCR Research GPCRLigNet: rapid screening for GPCR active ligands using machine Insights into GPCR Function Structure-based design of novel melanin-concentrating hormone receptor-1 ligands Studentship - Integrated Approaches In Pharmacology, Computer Simulations And Machine Learning To Predict Ligand

  • 📰 GPCR Weekly News, October 23 to 29, 2023

    through Transcriptomics and Single-Cell Technologies Methods & Updates in GPCR Research ThermoBRET: A Ligand-Engagement Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    Dual control: not just brightness but fluorescence lifetime, with drastic shifts as pH drops.

  • 📰 GPCR Weekly News, December 11 to 17, 2023

    Ross Cheloha's research involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional complex unravels the biased signaling mechanism GPCR Binders, Drugs, and more Semi-synthetic nanobody-ligand Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • Five GPCR Masterclasses Before The Summer

    Dmitry Veprintsev  — Biophysical Approaches to Study Orphan GPCR Ligand Binding and Signalling.

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    Before your GPCR ligand ever meets its receptor, it meets the enzymes that determine whether it survives Discovery Program So what does that mean for discovery scientists designing the next generation of GPCR ligands Even the most elegant GPCR ligand can fail if it never reaches its receptor.

  • Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

    is the removal of the inhibitory GAIN domain and the dipping of the cleaved stalk peptide into the ligand-binding The structures reveal unique ligand-engaging mode, distinctive activation conformation, and key mechanisms

  • Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks

    This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function

  • Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...

    employed optical assays in living cells to thoroughly profile both GPR35 isoforms for constitutive and ligand-induced activation and signaling of 10 different heterotrimeric G proteins, ligand-induced arrestin recruitment and mechanistic insights of our study provide clues for the future design of isoform-specific GPR35 ligands

  • Activation of the human chemokine receptor CX3CR1 regulated by cholesterol

    2022 "As the only member of the CX3C chemokine receptor subfamily, CX3CR1 binds to its sole endogenous ligand Here, we present two cryo-electron microscopy structures of CX3CR1-Gi1 complexes in ligand-free and CX3CL1

  • GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis

    Synaptamide suppressed osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand Our study suggested that ligands of GPR110, such as synaptamide, might be a useful drug for osteoporotic

  • Structures of oxysterol sensor EBI2/GPR183, a key regulator of the immune response

    These structures reveal an agonist binding site for the oxysterol and a potential ligand entrance site Together, these findings provide new insight into how EBI2 is activated by an oxysterol ligand and will

  • Interacting binding insights and conformational consequences of the differential activity of...

    dual contrasting functional feature of CBD, that is, displaying antagonistic and (possible) agonistic ligand From microsecond-length unbiased molecular dynamics simulations, we found that the presence of the CBD ligand These results are in agreement with the proposed modulatory function of each ligand, showing that the In contrast to the CBD/CB1 complex, when the CB1 receptor is simulated in complex with the ligand antagonist

  • Multifunctional role of GPCR signaling in epithelial tube formation

    During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent

  • 📰 GPCR Weekly News, March 11 to 17, 2024

    in brain intercellular signaling Are there sex differences in oxytocin and vasopressin V1a receptors ligand that is now part of Bristol Myers Squibb GPCR Events, Meetings, and Webinars March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • Structural landscape of the Chemokine Receptor system

    The arrangement of the seven transmembrane helices creates a ligand-binding cavity on the extracellular Activation in Class A GPCRs Ligand binding in the orthosteric site leads to diverse activation mechanisms road map of CCR5 and CCR2 activation The structure of CCR5 has been studied in complex with various ligands The agonist ligands (CCL5, CCL3, and [6P4]CCL5) bind to the 7TM cavity with their N-termini adopting promiscuity within subfamilies, functionally selective biased ligands, and constitutively active and

  • Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...

    A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent this field has exploded during the past two decades, it is only recently that highly β-arrestin biased ligands

  • Multifunctional role of GPCR signaling in epithelial tube formation

    During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent

  • 📰 GPCR Weekly News, June 12 to 18, 2023

    Methods & Updates in GPCR Research Spatiotemporal GPCR signaling illuminated by genetically encoded fluorescent

  • Amylin Receptor Signaling: Three Receptors From One, and How to Profile Each

    A ligand that favors cAMP over β-arrestin, or the reverse, can produce a meaningfully different functional These systems provide quantitative readouts of ligand activity across both cAMP signaling and β-arrestin

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    This Week’s GPCR Intelligence: If you want cleaner decisions, start with the system—then the ligand. GPCR; a bidirectional GPCR switch modulates immune signaling; a machine-learning tool predicts GPCR–ligand

  • When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA

    selectivity and efficacy shifts It becomes critical in both screening strategy and therapeutic positioning As ligand diversity expands — including peptide agonists and biased ligands — ignoring probe dependence risks

  • 📰 GPCR Weekly News, August 21 to 27, 2023

    mechanisms and therapeutic targets in atopic diseases Methods & Updates in GPCR Research TrGPCR:GPCR-ligand NEW February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition NEW March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar NEW March 24 - 29, 2024 | Ligand Recognition and Molecular

  • 📰 GPCR Weekly News, January 1 to 7, 2024

    adhesion G-protein-coupled receptor mayo/CG11318 controls midgut development in Drosophila Structure, ligands Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating

  • Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024

    De Graaf   for their excellent work on Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Molecular Insights into GPCR Function Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability

bottom of page